Phase 1 Study of the Safety and Immunogenicity of RiVax With Alum in Healthy Adults.
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Ricin vaccine (Primary) ; Alum
- Indications Ricin poisoning
- Focus Adverse reactions
- 19 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Aug 2012 Planned End Date changed from 1 Jan 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 03 Nov 2010 Status changed from recruiting to active, no longer recruiting, according to Soligenix media release.